Advances in Biological Regulation

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Advances in Biological Regulation is a journal published by Elsevier BV. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,880 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
2212-4934 · 2212-4926
Access
Not open access / not declared
Declared publication charge
3,880 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2012-01-01
Indexing
MEDLINE
APC
3,880 USD
Declared review time (DOAJ)
—
Actual review time (measured)
14 days received→accepted — computed from PubMed (n=61)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

647

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

69

i10-index

364

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
72%
ORCID iDs in current deposits
59%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101572336
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Protein Kinase Regulation and GTPase Signaling
  • Protein Kinase Regulation and GTPase Signaling
  • Cellular transport and secretion
  • Cellular transport and secretion
  • PI3K/AKT/mTOR signaling in cancer
  • PI3K/AKT/mTOR signaling in cancer
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
Show all subjects (50)
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Sphingolipid Metabolism and Signaling
  • Sphingolipid Metabolism and Signaling
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Endoplasmic Reticulum Stress and Disease
  • Endoplasmic Reticulum Stress and Disease
  • Acute Myeloid Leukemia Research
  • Lipid Membrane Structure and Behavior
  • Lipid Membrane Structure and Behavior
  • Acute Myeloid Leukemia Research
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Ubiquitin and proteasome pathways
  • Ubiquitin and proteasome pathways
  • Pancreatic function and diabetes
  • Pancreatic function and diabetes
  • RNA Research and Splicing
  • RNA Research and Splicing
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Metabolism, Diabetes, and Cancer
  • Metabolism, Diabetes, and Cancer
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Acute Lymphoblastic Leukemia research
  • Cell death mechanisms and regulation
  • Cell death mechanisms and regulation
  • COVID-19 Clinical Research Studies
  • Acute Lymphoblastic Leukemia research
  • COVID-19 Clinical Research Studies
  • Lipid metabolism and biosynthesis
  • Lipid metabolism and biosynthesis
  • Immune Cell Function and Interaction
  • Mitochondrial Function and Pathology
  • Mitochondrial Function and Pathology
  • Immune Cell Function and Interaction
  • Nuclear Structure and Function
  • Nuclear Structure and Function

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: